APA (7th ed.) Citation

Hou, C., Xiong, B., Zhou, L., Fei, Y., Shi, C., Zhu, X., . . . Wu, Y. (2024). Transarterial chemoembolization with molecular targeted therapies plus camrelizumab for recurrent hepatocellular carcinoma. BMC Cancer, 24(1), 1. https://doi.org/10.1186/s12885-024-12144-6

Chicago Style (17th ed.) Citation

Hou, Changlong, Baizhu Xiong, Lei Zhou, Yipeng Fei, Changgao Shi, Xianhai Zhu, Tao Xie, and Yulin Wu. "Transarterial Chemoembolization with Molecular Targeted Therapies Plus Camrelizumab for Recurrent Hepatocellular Carcinoma." BMC Cancer 24, no. 1 (2024): 1. https://doi.org/10.1186/s12885-024-12144-6.

MLA (9th ed.) Citation

Hou, Changlong, et al. "Transarterial Chemoembolization with Molecular Targeted Therapies Plus Camrelizumab for Recurrent Hepatocellular Carcinoma." BMC Cancer, vol. 24, no. 1, 2024, p. 1, https://doi.org/10.1186/s12885-024-12144-6.